GREEN ANDREW M sold $911K of AORT
GREEN ANDREW M (SVP, Regulatory and Quality) sold 44,001 shares of ARTIVION, INC. (AORT) at an average of $20.70 ($20.69–$20.71, $0.91M total) across 2 trades on 2026-06-11 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the officer’s open-market sale size, price range, and confirmation of a pre-arranged 10b5-1 plan; there is no stated business development or financial update.
Market read
Traders may note the insider sale for sentiment, but the 10b5-1 structure and lack of fundamental catalysts keep impact modest.
What to watch
The article provides only the sale details; it does not include any offsetting insider buys, changes in guidance, or company-specific news that would contextualize the sale.
Background
The article is an SEC Form 4 insider transaction disclosure for Artivion, Inc. (AORT).
Ticker impact
Artivion (AORT) disclosed an SVP regulatory/quality insider open-market sale of 44,001 shares at ~$20.70 via a Form 4.
Likely limited immediate price impact; any effect would be sentiment-driven and short-lived.
The filing is a routine Form 4 open-market sale by an officer under a pre-arranged 10b5-1 plan, with no accompanying operational or financial catalyst stated.
Market effects
No sector-level implications; this is company-specific insider transaction disclosure.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can still be interpreted by some traders as a mild negative signal about near-term risk or liquidity needs.
Key entities
- issuerARTIVION, INC.
Subject of the Form 4 insider transaction disclosure.
- insiderGREEN ANDREW M
SVP, Regulatory and Quality who sold 44,001 shares under an open-market sale (10b5-1 plan).
